InvestorsHub Logo

HIM

Followers 141
Posts 7182
Boards Moderated 1
Alias Born 07/06/2006

HIM

Member Level

Re: None

Monday, 06/06/2011 8:55:13 AM

Monday, June 06, 2011 8:55:13 AM

Post# of 26138
Biosante Pharmaceuticals Inc (NASDAQ: BPAX) shares advanced 7.97% to $3.25 in the pre-market session.

BPAX reported lifting of clinical hold on the GVAX Prostate Cancer Vaccine (GVAX Prostate) by FDA.

Link:

http://www.benzinga.com/markets/11/06/1140398/benzingas-top-pre-market-nasdaq-gainers

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.